Eugenol acetateCAS# 93-28-7 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 93-28-7 | SDF | Download SDF |
PubChem ID | 7136 | Appearance | Colorless liquid |
Formula | C12H14O3 | M.Wt | 206.24 |
Type of Compound | Simple Phenylpropanoids | Storage | Desiccate at -20°C |
Synonyms | Eugenol acetate | ||
Solubility | Soluble in ethanol and methanol; insoluble in water | ||
Chemical Name | (2-methoxy-4-prop-2-enylphenyl) acetate | ||
SMILES | CC(=O)OC1=C(C=C(C=C1)CC=C)OC | ||
Standard InChIKey | SCCDQYPEOIRVGX-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C12H14O3/c1-4-5-10-6-7-11(15-9(2)13)12(8-10)14-3/h4,6-8H,1,5H2,2-3H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Eugenol acetate Dilution Calculator
Eugenol acetate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.8487 mL | 24.2436 mL | 48.4872 mL | 96.9744 mL | 121.218 mL |
5 mM | 0.9697 mL | 4.8487 mL | 9.6974 mL | 19.3949 mL | 24.2436 mL |
10 mM | 0.4849 mL | 2.4244 mL | 4.8487 mL | 9.6974 mL | 12.1218 mL |
50 mM | 0.097 mL | 0.4849 mL | 0.9697 mL | 1.9395 mL | 2.4244 mL |
100 mM | 0.0485 mL | 0.2424 mL | 0.4849 mL | 0.9697 mL | 1.2122 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Alizarin 1-methyl ether
Catalog No.:BCN9064
CAS No.: 6170-06-5
- D-Ribose
Catalog No.:BCN9063
CAS No.:50-69-1
- α-L-Rhamnopyranose
Catalog No.:BCN9062
CAS No.:6014-42-2
- (±)-Naringenin
Catalog No.:BCN9061
CAS No.:67604-48-2
- Glucodigifucoside
Catalog No.:BCN9060
CAS No.:2446-63-1
- Trimethyl phosphate
Catalog No.:BCN9059
CAS No.:512-56-1
- N-Phenethylbenzamide
Catalog No.:BCN9058
CAS No.:3278-14-6
- Warfarin sodium
Catalog No.:BCN9057
CAS No.:129-06-6
- Flavokawain A
Catalog No.:BCN9056
CAS No.:37951-13-6
- 5'-Guanylic acid
Catalog No.:BCN9055
CAS No.:85-32-5
- Xanthosine
Catalog No.:BCN9054
CAS No.:146-80-5
- 5'-Cytidylic acid
Catalog No.:BCN9053
CAS No.:63-37-6
- Citral
Catalog No.:BCN9066
CAS No.:5392-40-5
- 10-hydroxydec-2-enoic acid
Catalog No.:BCN9067
CAS No.:14113-05-4
- Citronellal
Catalog No.:BCN9068
CAS No.:106-23-0
- Benzyl alcohol
Catalog No.:BCN9069
CAS No.:100-51-6
- (-)-Menthone
Catalog No.:BCN9070
CAS No.:14073-97-3
- (+)-Fenchone
Catalog No.:BCN9071
CAS No.:4695-62-9
- Alphalipoic acid
Catalog No.:BCN9072
CAS No.:1077-28-7
- Ferulic Acid Methyl Ester
Catalog No.:BCN9073
CAS No.:2309-07-1
- 3-(β-D-Glucopyranosyloxy)-1,6-dihydroxy-2-methyl-9,10-anthracenedione
Catalog No.:BCN9074
CAS No.:125906-49-2
- (-)-Fenchone
Catalog No.:BCN9075
CAS No.:7787-20-4
- (1S)-(-)-α-Pinene
Catalog No.:BCN9076
CAS No.:7785-26-4
- (S)-(+)-Carvone
Catalog No.:BCN9077
CAS No.:2244-16-8
Appetite-enhancing effects of inhaling cinnamon, clove, and fennel essential oils containing phenylpropanoid analogues.[Pubmed:32556946]
J Nat Med. 2020 Jun 15. pii: 10.1007/s11418-020-01423-8.
Cinnamon, clove, and fennel are commonly used as spices and herbal medicines, and one of their medicinal uses is as aromatic stomachics. We investigated the effect on appetite in mice of inhaling volatile compounds contained in essential oils extracted from herbal medicines used as aromatic stomachics. The appetite-enhancing effects of cinnamon and fennel essential oils were similar to those of their main components trans-cinnamaldehyde and trans-anethole, respectively. The appetite-enhancing effects of clove essential oil were observed over a wide range of doses (4.5 x 10(-4) to 4.5 x 10(-3) mg/cage), even though the active compounds showed effects within a narrow range of doses (eugenol: 4.5 x 10(-4) to 2.5 x 10(-3) mg/cage; Eugenol acetate: 1.1 x 10(-3) to 4.5 x 10(-3) mg/cage). The increase in appetite at doses that differed by tenfold in mice administered clove oil was due to synergistic effects between eugenol and Eugenol acetate in clove oil. Thus, loss of appetite could be treated more effectively using essential oil containing both eugenol and Eugenol acetate compared with the active compounds administered separately. Administering essential oils, such as cinnamon and clove, could improve loss of appetite without strict dosage adjustment.